This would suggest that MOC2 tumors develop metastases with immunosuppressive characteristics, which do not respond to antitumor immune signals, even in the animals where the tumor shows a synergistic response to radiation and anti-PDL1. The gene discussed is CD274; the disease is neoplasm.